Home
Conditions
Urothelial Carcinoma

Clinical trial condition

Urothelial Carcinoma

Explore clinical trials studying Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.

239 public trials 74 recruiting studies

Refine in advanced search Browse all conditions

Urothelial Carcinoma trial results

Recruiting

Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)

NCT06396533

Conditions: Carcinoma, Carcinoma, Transitional Cell, Muscle Invasive Bladder Urothelial Carcinoma, +5 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT03452774

Conditions: Adenocarcinoma, Adnexal Diseases, Astrocytoma, +144 more
Locations: Massive Bio SYNERGY-AI site Birmingham, Alabama, United States

Massive Bio SYNERGY-AI site Mobile, Alabama, United States

Massive Bio SYNERGY-AI site Scottsdale, Arizona, United States

Massive Bio SYNERGY-AI site Little Rock, Arkansas, United States

View all 68 locations

View Trial Details

Recruiting

Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer

NCT06310759

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations: Jesse Brown Department Of Veterans Affairs Medical Center Chicago, Illinois, United States

Vancouver Prostate Centre Vancouver, British Columbia, Canada

Helsinki University Hospital Helsinki, Finland

Satasairaala Hospital Pori, Finland

View Trial Details

Recruiting

A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors

NCT05965856

Conditions: Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +4 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinoma

NCT04678362

Conditions: Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations: Institut de Cancérologie de l'Ouest Angers, France

CHU Jean Minjoz Besançon, France

Centre François baclesse Caen, France

Centre Jean Perrin Clermont-Ferrand, France

View all 14 locations

View Trial Details

Recruiting

Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy

NCT04892849

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +30 more
Locations: Department of Radiation Oncology, Universitätsklinikum Erlangen Erlangen, Bavaria, Germany

View Trial Details

Recruiting

Compression Stockings to Prevent Peripheral Neuropathy Caused by Antibody-Drug Conjugates in Urothelial Carcinoma Patients

NCT07164950

Conditions: Advanced Solid Tumors, Antibody-drug Conjugates, Carcinoma, +6 more
Locations: Fudan University Shanghai Cancer Center Shanghai, China

View Trial Details

Recruiting

Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma

NCT06262516

Conditions: Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations: University of Florida Health Science Center Gainesville, Florida, United States

Southern Illinois University Springfield, Illinois, United States

University Hospitals Cleveland Medical Center, Urology Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Cleveland Clinic Glickman Urological and Kidney Institute Cleveland, Ohio, United States

View Trial Details

Recruiting

Ivonescimab in the Treatment of Multiple Advanced Tumors

NCT06683846

Conditions: Adenocarcinoma, Adrenal Cortical Cancer, Angiomyolipoma, +56 more
Locations: Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma

NCT07043972

Conditions: Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

Temple University Hospital at Broad Street Philadelphia, Pennsylvania, United States

View Trial Details

Urothelial Carcinoma

Urothelial Carcinoma trial results

Related conditions